Have noted that the founder of Chinese Pioneer Pharma Holdings (Paul Xinzhou Li) was a director of Paragon from January 2021 until September 2021, probably being part of the time when they were invested in Paragon Care. They must have sold out at a considerable loss considering their entry price, and when they sold.
Quite intriguing that they have once again made a substantial investment in Paragon only a few years after selling out.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.035(8.86%) |
Mkt cap ! $595.9M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 38.5¢ | 35.0¢ | $471.6K | 1.296M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 66023 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 35641 | 8 |
View Market Depth
| Last trade - 13.06pm 25/06/2025 (20 minute delay) ? |
| PGC (ASX) Chart |